You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 25, 2024

Details for Patent: 10,774,085


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,774,085
Title:Method of treatment using substituted pyrazolo[1,5-A] pyrimidine compounds
Abstract: Compounds useful in the synthesis of compounds for treating pain, cancer, inflammation, neurodegenerative disease or Typanosoma cruzi infection in a mammal.
Inventor(s): Haas; Julia (Boulder, CO), Andrews; Steven W. (Boulder, CO), Jiang; Yutong (Boulder, CO), Zhang; Gan (Stamford, CT)
Assignee: ARRAY BIOPHARMA INC. (Boulder, CO)
Application Number:16/044,653
Patent Claim Types:
see list of patent claims
Use; Delivery;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of a U.S. Patent: A Detailed Guide Using United States Patent 10,774,085 as an Example

Introduction

When analyzing a U.S. patent, understanding the scope and claims is crucial for determining its validity, enforceability, and potential impact on the market. This article will delve into the intricacies of patent scope and claims using United States Patent 10,774,085 as a case study.

Understanding Patent Scope

Patent scope refers to the breadth and depth of protection granted by a patent. It is a critical aspect of patent quality and can significantly influence innovation and litigation costs[3].

Metrics for Measuring Patent Scope

Two simple yet effective metrics for measuring patent scope are independent claim length and independent claim count. These metrics have been validated by showing their explanatory power for several correlates of patent scope, such as patent maintenance payments, forward citations, and the breadth of patent classes[3].

Patent Claims: The Heart of a Patent

Patent claims define the scope of the invention and are the legal boundaries of what the patent protects.

Types of Claims

  • Independent Claims: These claims stand alone and define the invention without reference to other claims.
  • Dependent Claims: These claims refer back to and further limit an independent claim.

Importance of Claim Language

The language used in patent claims is precise and technical. Broader claims can lead to longer examination processes and lower probabilities of grant, while narrower claims are associated with shorter examination processes and higher grant probabilities[3].

Case Study: United States Patent 10,774,085

To illustrate the analysis, let's consider United States Patent 10,774,085.

Identifying the Patent

To start, you would use the USPTO's Patent Public Search tool or other databases to locate the patent. This tool provides enhanced access to prior art and allows users to view the patent family, classification, and citation data[1].

Reading the Patent Document

The patent document includes several key sections:

  • Abstract: A brief summary of the invention.
  • Background of the Invention: Context and prior art related to the invention.
  • Summary of the Invention: A concise description of the invention.
  • Detailed Description of the Invention: A detailed explanation of the invention, including drawings and examples.
  • Claims: The legal definition of the invention.

Analyzing the Claims

For United States Patent 10,774,085, you would carefully read and analyze each claim to understand the scope of protection.

Independent Claims

Identify the independent claims, which are typically the broadest claims in the patent. These claims define the core of the invention.

Dependent Claims

Analyze the dependent claims, which further limit the independent claims. These claims often add specific details or features to the invention.

Evaluating Claim Language

Assess the length and count of independent claims. Broader claims may indicate a wider scope of protection but could also face more scrutiny during the examination process[3].

International and Global Context

Patents are often part of a global patent family, with related applications filed in multiple countries.

Global Dossier

Use the Global Dossier service to view the file histories of related applications from participating IP Offices. This can provide insights into the patent family and how the invention is protected globally[1].

Searching International Patent Offices

Check databases from other international intellectual property offices, such as the European Patent Office (EPO), Japan Patent Office (JPO), and World Intellectual Property Organization (WIPO), to see if similar patents have been granted or applied for in other countries[1].

Tools and Resources for Patent Analysis

Several tools and resources are available to aid in patent analysis:

Patent Public Search

The USPTO's Patent Public Search tool offers modern interfaces for enhanced access to prior art and patent documentation[1].

Patent and Trademark Resource Centers (PTRCs)

Local PTRCs provide training and resources for patent search techniques, which can be invaluable for thorough analysis[1].

Common Citation Document (CCD)

The CCD application consolidates prior art cited by participating offices, helping to visualize search results on a single page[1].

Legal and Policy Considerations

Understanding the legal and policy framework surrounding patents is essential.

Small Claims Patent Court

There have been discussions and studies on the feasibility of a small claims patent court to address issues related to patent litigation costs and accessibility. Such a court could impact how patent disputes are resolved, particularly for small inventors and businesses[5].

Practical Steps for Conducting a Preliminary Patent Search

Step-by-Step Strategy

Use the USPTO's step-by-step strategy for conducting a preliminary U.S. patent search. This includes using the Patent Public Search tool, searching international databases, and consulting local PTRCs[1].

Training and Assistance

Utilize resources like the USPTO Public Search Facility and local PTRCs for training and assistance in patent search techniques[1].

Conclusion

Analyzing the scope and claims of a U.S. patent, such as United States Patent 10,774,085, involves a detailed examination of the patent document, use of various tools and resources, and an understanding of the global and legal context.

Key Takeaways

  • Patent Scope: Metrics like independent claim length and count are crucial for measuring patent scope.
  • Claim Language: Precise and technical language in claims defines the invention's legal boundaries.
  • Global Context: Use Global Dossier and international patent databases to understand the global patent family.
  • Tools and Resources: Utilize the USPTO's Patent Public Search, PTRCs, and CCD for thorough analysis.
  • Legal Considerations: Be aware of legal and policy discussions, such as the potential for a small claims patent court.

FAQs

Q: How do I find a specific U.S. patent?

A: You can use the USPTO's Patent Public Search tool or other databases like PATENTSCOPE to locate a specific patent by its number or keywords.

Q: What is the difference between independent and dependent claims?

A: Independent claims stand alone and define the invention, while dependent claims refer back to and further limit an independent claim.

Q: How can I determine the global scope of a patent?

A: Use the Global Dossier service and search international patent databases to view related applications and the global patent family.

Q: What resources are available for training in patent search techniques?

A: The USPTO Public Search Facility and local Patent and Trademark Resource Centers (PTRCs) offer training and assistance.

Q: Why is claim language important in a patent?

A: Claim language defines the legal boundaries of the invention and affects the patent's scope and enforceability.

Sources

  1. USPTO: Search for patents - USPTO.
  2. USA.gov: U.S. Patent and Trademark Office (USPTO) | USAGov.
  3. SSRN: Patent Claims and Patent Scope.
  4. NCSES: Invention, Knowledge Transfer, and Innovation.
  5. ACUS: U.S. Patent Small Claims Court.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,774,085

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Bayer Hlthcare VITRAKVI larotrectinib sulfate CAPSULE;ORAL 210861-001 Nov 26, 2018 RX Yes No 10,774,085 ⤷  Subscribe METHOD OF TREATING SOLID TUMORS THAT EXHIBIT AN NTRK GENE FUSION ⤷  Subscribe
Bayer Hlthcare VITRAKVI larotrectinib sulfate CAPSULE;ORAL 210861-002 Nov 26, 2018 RX Yes Yes 10,774,085 ⤷  Subscribe METHOD OF TREATING SOLID TUMORS THAT EXHIBIT AN NTRK GENE FUSION ⤷  Subscribe
Bayer Healthcare VITRAKVI larotrectinib sulfate SOLUTION;ORAL 211710-001 Nov 26, 2018 RX Yes Yes 10,774,085 ⤷  Subscribe METHOD OF TREATING SOLID TUMORS THAT EXHIBIT AN NTRK GENE FUSION ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,774,085

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 3106463 ⤷  Subscribe 301033 Netherlands ⤷  Subscribe
European Patent Office 3106463 ⤷  Subscribe PA2020504 Lithuania ⤷  Subscribe
European Patent Office 3106463 ⤷  Subscribe CA 2020 00013 Denmark ⤷  Subscribe
European Patent Office 3106463 ⤷  Subscribe 122020000012 Germany ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.